Development of the measure of ovarian symptoms and treatment concerns: aiming for optimal measurement of patient-reported symptom benefit with chemotherapy for symptomatic ovarian cancer.

@article{King2014DevelopmentOT,
  title={Development of the measure of ovarian symptoms and treatment concerns: aiming for optimal measurement of patient-reported symptom benefit with chemotherapy for symptomatic ovarian cancer.},
  author={Madeleine T King and Martin Richard Stockler and Phyllis Butow and Rachel L. O'Connell and Merryn Voysey and Amit Manulal Oza and K. R. Gillies and Heidi S Donovan and Rebecca Mercieca-Bebber and Julie K Martyn and Katrin M. Sjoquist and Michael Friedlander},
  journal={International journal of gynecological cancer : official journal of the International Gynecological Cancer Society},
  year={2014},
  volume={24 5},
  pages={865-73}
}
OBJECTIVE The aim of this study was to determine the optimal patient-reported outcome measure (PROM) for assessing symptom benefit in trials of palliative chemotherapy for women with symptomatic ovarian cancer. METHODS Candidate PROMs were EORTC QLQ-C30 plus ovarian-specific QLQ-OV28, Functional Assessment of Cancer Therapy-Ovarian (FACT-O), FACT Ovarian Symptom Index (FOSI), and gynecologic cancer-specific Symptom Representation Questionnaire. Predefined optimality criteria were inclusion of… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 3 times over the past 90 days. VIEW TWEETS
7 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-7 of 7 extracted citations

Similar Papers

Loading similar papers…